Texas Yale Capital Corp’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-10,913
Closed -$787K – 477
2022
Q1
$787K Hold
10,913
– – 0.04% 270
2021
Q4
$1M Hold
10,913
– – 0.05% 245
2021
Q3
$1.38M Hold
10,913
– – 0.08% 207
2021
Q2
$1.81M Hold
10,913
– – 0.1% 175
2021
Q1
$1.98M Hold
10,913
– – 0.12% 154
2020
Q4
$2.18M Sell
10,913
-475
-4% -$96.6K 0.15% 138
2020
Q3
$2.5M Buy
11,388
+475
+4% +$101K 0.19% 109
2020
Q2
$2.08M Sell
10,913
-145
-1% -$25.4K 0.17% 124
2020
Q1
$1.71M Sell
11,058
-201
-2% -$23.4K 0.17% 122
2019
Q4
$943K Buy
11,259
+491
+5% +$37.4K 0.06% 248
2019
Q3
$729K Buy
+10,768
New +$709K 0.05% 276

Other funds holding TDOC

Texas Yale Capital Corp's TDOC Position: Q2 2022 in Review

Texas Yale Capital Corp sold out of Teladoc Health (TDOC) in Q2 2022, closing a stake of 10,913 shares — an estimated $787K sold.

Texas Yale Capital Corp first reported a position in TDOC in Q3 2019 and held it in 11 quarters. The position peaked at $2.5M in Q3 2020. 551 funds tracked by Wall St. Rank hold TDOC as of Q2 2022.

  • Texas Yale Capital Corp reported no remaining Teladoc Health position as of Q2 2022 after selling out during the quarter.
  • Texas Yale Capital Corp sold 10,913 Teladoc Health shares in Q2 2022, an estimated $787K.
  • Texas Yale Capital Corp first reported a position in Teladoc Health in Q3 2019 and held it in 11 quarters.
  • Texas Yale Capital Corp's Teladoc Health position peaked at $2.5M in Q3 2020.
  • 551 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2022.

Based on Texas Yale Capital Corp's 13F filing for Q2 2022, filed 11 Aug 2022.